对于聚合物外微气泡的脑瘤毒性概况的治疗方法
Gaio Paradossi1, Fabio Domenici1, Francesco Riccitelli1
1Dipartimento di Scienze e Tecnologie Chimiche, Università degli Studi di Roma Tor Vergata, 00133 Roma, Italy.
ACS omega
|February 17, 2025
概括
结合成像和化疗的新型微泡 (MB) 显示出恶性质瘤治疗的前景. 低剂量给老鼠的治疗证明了安全性,为未来在脑瘤治疗中的疗效研究铺平了道路.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 恶性质质瘤带来了重大的治疗挑战.
- 结合成像和药物输送的治疗神经设备提供了潜在的优势.
- 新型微气泡 (MBs) 已开发用于多式联网应用.
研究的目的:
- 评估新型聚乙醇微气泡 (PVA MBs) 的潜在毒性,这些微气泡是为脑瘤治疗而设计的.
- 在大鼠模型中评估近红外 (NIR) 成像和temozolomide (TMZ) 药物输送的MBs的安全性.
主要方法:
- 鼠被静脉注射裸体MB,使用NIR成像和向配体的MB (MB-C790-RGD),以及使用成像,向和化疗的MB (MB-C790-RGD-TMZ).
- 给出了两个剂量,在注射后10分钟和7天评估了毒性.
- 评估包括死亡率,血液学参数,器官重量和组织病理学.
主要成果:
- 在为期7天的研究期间,在任何组中都没有观察到死亡率.
- 高剂量裸体MB和MB-C790-RGD组显示血红蛋白/血红素的降低和甘油三的增加,与大/肝脏有关.
- 组织病理学揭示了高剂量动物在7天后的治疗相关的炎症.
结论:
- 在老鼠中,低剂量给药的新型疗效微气泡似乎是安全的.
- 这些发现支持在恶性质瘤治疗临床应用之前继续进行疗效研究.
- 这项技术有可能改善脑瘤手术和治疗.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


